Radiopharm Theranostics (RAD.AX) Earnings Analysis
Radiopharm Theranostics (RAD.AX) next reports earnings on 2026-09-24, consensus EPS -0.01 AUD. Last quarter (2026-02-26) it missed with EPS -0.0105 AUD vs -0.00756 AUD est (-38.9%). It has beaten estimates in 0/3 recent quarters (0%). Trailing P/E -1.24.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does RAD.AX next report earnings?
| Next earnings date | 2026-09-24 |
|---|---|
| Consensus EPS estimate | -0.01 AUD |
| Revenue estimate | 0.00B |
RAD.AX earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-02-26 | -0.0105 AUD | -0.00756 AUD | -38.9% | Miss |
| 2025-02-28 | -0.0102 AUD | -0.01 AUD | -2% | Miss |
| 2024-08-30 | -0.06356 AUD | -0.01 AUD | -535.6% | Miss |
Beat rate: 0/3 (0%) over reported quarters with consensus data.
RAD.AX valuation and analyst view
| Trailing P/E | -1.24 |
|---|---|
| Trailing EPS | -0.01268 AUD |
| Price / book | 1.30 |
| Dividend yield | 0.00% |
| Market cap | 0.04B |
Limited or no published sell-side analyst coverage for this symbol.
Related research pages
Frequently asked questions
When is Radiopharm Theranostics (RAD.AX)'s next earnings date?
Radiopharm Theranostics is next scheduled to report on 2026-09-24, with a consensus EPS estimate of -0.01 AUD and revenue estimate of 0.00B.
Did RAD.AX beat earnings last quarter?
In its 2026-02-26 report, RAD.AX posted EPS of -0.0105 AUD versus a -0.00756 AUD estimate — a miss of 38.9%.
What is RAD.AX's earnings track record?
Over the last 3 reported quarters with consensus data, RAD.AX beat estimates 0 times (0%).
What is RAD.AX's current P/E ratio and EPS?
RAD.AX trades at a trailing P/E of -1.24 on trailing EPS of -0.012680690728524865 AUD.
What do analysts rate RAD.AX?
RAD.AX has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.